Efek Sinbiotik Jamur Tiram Teraktivasi UVB dan Air Kelapa Muda terhadap Integritas Kolon dan Survival Tikus Kolitis
DOI:
https://doi.org/10.59680/anestesi.v4i1.2551Keywords:
Colitis, Goblet Cells, Probiotics, UVB-Activated Oyster Mushroom, Young Coconut WaterAbstract
Colitis is an inflammatory disorder of the colon characterized by disruption of immune homeostasis and damage to the intestinal mucosa. Synbiotics play an important role in immune regulation, while UVB-activated oyster mushroom (Pleurotus ostreatus) is a potential source of vitamin D2 with anti-inflammatory properties. The combination of these components with young coconut water may offer a beneficial approach to ameliorating colitis. This study aimed to investigate the effects of Debiococo, a combination of UVB-activated oyster mushroom powder, probiotics, and young coconut water, on colitis symptoms, colonic mucosal integrity, and survival rate in rats with acetic acid-induced colitis. This experimental study used a posttest-only control group design involving 30 male Wistar rats randomly divided into five groups: normal control, negative control, positive control treated with sulfasalazine, Debiococo dose 1, and Debiococo dose 2. Colitis was induced through intrarectal administration of 4% acetic acid, followed by treatment for eight days. The observed parameters included colitis symptoms, goblet cell count, and survival rate. The results showed significant differences in goblet cell counts among groups (p < 0.001), with Debiococo dose 2 producing goblet cell counts comparable to those of the normal control group. In addition, Debiococo dose 2 maintained the survival of all experimental animals until the end of the observation period and achieved the highest survival rate among the colitis groups. These findings indicate that Debiococo has potential as a synbiotic-based adjunct therapy for maintaining colonic mucosal integrity and improving survival outcomes in colitis conditions.
References
Bu, F., Chen, K., Chen, S., & Jiang, Y. (2025). Gut microbiota and intestinal immunity interaction in ulcerative colitis and its application in treatment. Frontiers in Cellular and Infection Microbiology, Volume 15-2025. https://doi.org/10.3389/fcimb.2025.1565082
El-ramady, H., Velasco, F., Llanaj, X., Nguyen, D. H. H., & Peles, F. (2023). Modulation of the Gut Microbiota with Prebiotics and Antimicrobial Agents from Pleurotus ostreatus Mushroom.
Gavzy, S. J., Kensiski, A., Lee, Z. L., Mongodin, E. F., & Ma, B. (2023). Bifidobacterium mechanisms of immune modulation and tolerance ABSTRACT. Gut Microbes, 15(2). https://doi.org/10.1080/19490976.2023.2291164
Hu, Y., Jin, X., Gao, F., Lin, T., & Zhu, H. (2022). Selenium-enriched Bifidobacterium longum DD98 effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. August, 1–16. https://doi.org/10.3389/fmicb.2022.955112
Hussaana, A., Revoni, F., Aulia, I., Dea, A., Pradana, D., Agustina, T., & Taufiq, H. (2024). Enhancement of Vitamin D2 Levels in Pleurotus ostreatus Using Ultraviolet Irradiation and Assessing Its Effect on Dexamethasone-Induced Osteoporosis in Mice. Indonesian Journal of Pharmacy, 35(2), 250–258. https://doi.org/10.22146/ijp.8252
Lin, S., Mukherjee, S., Li, J., Hou, W., Pan, C., & Liu, J. (2022). Mucosal immunity – mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer ’ s patches. May 2021, 1–16.
Liu, Y., Fang, F., Xiong, Y., Wu, J., & Li, X. (2022). Reprogrammed fecal and mucosa-associated intestinal microbiota and weakened mucus layer in intestinal goblet cell- speci fi c Piezo1-de fi cient mice. November, 1–12. https://doi.org/10.3389/fcimb.2022.1035386
Liu, Z., Jiang, Z., Zhang, Z., Liu, T., Fan, Y., & Liu, T. (2022). Bacillus coagulans in Combination with Chitooligosaccharides Regulates Gut Microbiota and Ameliorates the DSS-Induced Colitis in Mice. 10(4), 1–13.
Ma, W., Lian, L., Guo, L., Wu, Y., & Huang, L. (2025). A synbiotic combination of mixed probiotics and oligofructose restores intestinal microbiota disturbance in DSS-induced colitis in mice. July. https://doi.org/10.3389/fmicb.2025.1582155
Marietta, E., Huang, J., Zhang, J., & Wang, F. (2024). Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis. August, 1–14. https://doi.org/10.3389/fimmu.2024.1445838
Mödl, B., Awad, M., Zwolanek, D., Scharf, I., Schwertner, K., Milovanovic, D., Moser, D., Schmidt, K., Pjevac, P., Hausmann, B., Krauß, D., Mohr, T., Svinka, J., Kenner, L., Casanova, E., Timelthaler, G., Sibilia, M., Krieger, S., & Eferl, R. (2023). Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO Reports, 24(10), e57084. https://doi.org/10.15252/embr.202357084
Nova, F. S., Chasani, S., Hussanna, A., & Zulaikhah, S. T. (2020). Tender coconut water Inhibits the process of lipid peroxidation, reduce glucose levels, and increase plasma insulin in pregnant diabetic rats. Pharmacognosy Journal, 12(1), 162–167. https://doi.org/10.5530/pj.2020.12.24
Olivier, S., Diounou, H., Pochard, C., Frechin, L., Durieu, E., Foretz, M., Neunlist, M., Rolli-derkinderen, M., & Viollet, B. (2022). Intestinal Epithelial AMPK Deficiency Causes Delayed Colonic Epithelial Repair in DSS-Induced Colitis.
Popov, J., Caputi, V., Nandeesha, N., & Rodriguez, D. A. (2021). Microbiota-Immune Interactions in Ulcerative Colitis and Colitis Associated Cancer and Emerging Microbiota-Based Therapies.
Singh, V., Johnson, K., Yin, J., Lee, S., Lin, R., Yu, H., In, J., Foulke-abel, J., Zachos, N. C., Donowitz, M., & Rong, Y. (2021). Chronic In fl ammation in Ulcerative Colitis Causes Long-Term. Cellular and Molecular Gastroenterology and Hepatology, 13(1), 219–232. https://doi.org/10.1016/j.jcmgh.2021.08.010
Vernia, F., Valvano, M., Longo, S., Cesaro, N., Viscido, A., & Latella, G. (2022). Action and Therapeutic Implications.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dian Rudy Yana, Shendy Meian Nimas Nurinda, Atina Hussaana, Siti Thomas Zulaikhah, Conita Yuniarifa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
